Skip to main content
Harbin Pharmaceutical Group Co.,Ltd. logo

Harbin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600664 ISIN · CNE0000009T3 LEI · 300300G0L086UJ23MI26 Shanghai Stock Exchange Manufacturing
Filings indexed 1,827 across all filing types
Latest filing 2020-04-22 Notice of Dividend Amou…
Country CN China
Listing Shanghai Stock Exchange 600664

About Harbin Pharmaceutical Group Co.,Ltd.

https://www.hayao.com/

Harbin Pharmaceutical Group Co., Ltd. specializes in the research, development, manufacture, and distribution of a diverse range of pharmaceutical and healthcare products. The company's portfolio includes antibiotics, over-the-counter (OTC) medicines, health supplements, traditional Chinese medicines, and animal health products. It operates through several specialized subsidiaries and maintains a significant presence in the production of penicillins and cephalosporins. A key strategic focus involves the health and nutrition sector, bolstered by the acquisition of global nutrition brand GNC. The company leverages large-scale manufacturing capabilities and an extensive distribution network to serve both domestic and international markets. Its operations emphasize technological innovation and quality control across its integrated supply chain, from raw material production to finished dosage forms.

Recent filings

Filing Released Lang Actions
独立董事关于公司2019年度利润分配的预案的独立意见
Notice of Dividend Amount Classification · 90% confidence The document is an independent director's opinion on the company's 2019 profit distribution plan. It references the company's net profit, legal provisions, and dividend distribution decisions. The content focuses on the approval and opinion regarding the profit distribution proposal rather than presenting full financial statements or detailed financial results. The document length is short (615 characters), and it does not contain comprehensive financial data or analysis typical of an Annual Report or Interim Report. It is also not a simple announcement of a report publication but a formal opinion related to dividend distribution. This fits best under the category of Notice of Dividend Amount (DIV), as it relates to profit distribution and dividend decisions.
2020-04-22 Chinese
2019年度内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2019 年度内部控制评价报告' which translates to '2019 Annual Internal Control Evaluation Report'. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2019, including financial and non-financial internal control defects, their identification, and rectification status. The document is detailed and contains substantive information about internal control evaluation, which is typically part of audit-related disclosures. It is not an annual report (10-K) or interim report, nor is it a brief announcement or certification. The content aligns with an Audit Report / Information (AR) category, as it focuses on internal control evaluation and audit opinions related to internal controls, which is distinct from full annual financial statements. The document length is under 5,000 characters but contains detailed substantive content, not just an announcement or certification, so it is not RPA or RNS. Therefore, the best classification is AR with high confidence. FY 2019
2020-04-22 Chinese
独立董事关于公司对外担保情况的专项说明及独立意见
Audit Report / Information Classification · 90% confidence The document is a special statement and independent opinion by independent directors regarding the company's external guarantees, referencing regulatory notices from the China Securities Regulatory Commission and the company's 2019 audit report. It is a compliance and assurance statement rather than a full audit report or annual report. The document length is short (523 characters), and it does not contain full financial statements or detailed audit results, but rather an opinion on compliance with guarantee regulations. This fits best under Audit Report / Information (AR), which includes standalone audit-related reports and applied accounting principles, excluding full annual reports. FY 2019
2020-04-22 Chinese
关于公司吸收合并全资子公司的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the absorption merger of a wholly-owned subsidiary by the parent company. It details the board meeting approval, merger overview, parties involved, merger method, and impact on the company. There are no financial statements or detailed financial performance data presented, only summary information and procedural details. The document is relatively short (1818 characters) and serves as a formal announcement of a corporate restructuring event rather than a full report or detailed financial disclosure. This fits the category of a Capital/Financing Update (CAP) as it relates to changes in the company's capital structure and corporate organization through merger activities, but it is not a full merger filing (MA) or a regulatory filing (RNS) since it is specific to a merger announcement. Therefore, the best classification is CAP with high confidence.
2020-04-22 Chinese
独立董事关于会计政策变更的独立意见
Regulatory Filings Classification · 95% confidence The document is a statement from independent directors regarding a change in accounting policies. It references compliance with accounting standards and regulatory bodies but does not contain financial statements or detailed financial data. The document is short (512 characters) and serves as an opinion or certification rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which includes officer certifications and attestations related to accounting or governance matters.
2020-04-22 Chinese
2019年年度报告
Annual Report Classification · 100% confidence The document is titled '2019 年年度报告' which translates to '2019 Annual Report'. It contains detailed financial data, including profit and loss statements, cash flow statements, business overview, management discussion and analysis, and other comprehensive information typical of a full annual report. The document length is 15,000 characters, indicating a full report rather than a brief announcement. It includes audited financial statements and detailed sections on company business, financial performance, and governance. Therefore, this document fits the definition of an Annual Report (10-K). FY 2019
2020-04-22 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.